Combination Therapy for Fungal Nail Infections

Published Online: Wednesday, June 11, 2014
Follow Pharmacy_Times:
The results of a study published in the May 2014 issue of the Journal of the American Academy of Dermatology suggest that combining treatment with a fractional carbon-dioxide laser with topical antifungal therapy may be an effective treatment for fungal nail infections in patients who experience adverse reactions to systematic antifungal agents.

Related Articles
The FDA’s Anti-Infective Drugs Advisory Committee has recommended the approval of Astellas’ investigational antifungal drug, isavuconazonium, for the treatment of invasive aspergillosis and mucormycosis, which are life-threatening fungal infections primarily found in immunocompromised patients.
Astellas today announced that the FDA has granted orphan drug designation to isavuconazole for the treatment of invasive candidiasis, one of the most frequent invasive fungal infections detected in critically ill patients and a common cause of bloodstream infections.
Latest Issues